Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-4-23
pubmed:abstractText
Bone cells express glutamate-gated Ca2+-permeable N-methyl-D-aspartate (NMDA) receptors and GLAST glutamate transporters. Blocking NMDA receptors has been reported to reduce the number of bone resorption pits produced by osteoclasts, and mechanical loading alters GLAST transporter expression, which should change the extracellular glutamate concentration and NMDA receptor activation. Thus, by analogy with the brain, glutamate is postulated to be an important intercellular messenger in bone, controlling bone formation and resorption. We found that activating or blocking NMDA receptors had no effect on bone formation by rat osteoblasts in culture. The number of resorption pits produced by osteoclasts was reduced by the NMDA receptor blocker MK-801 but not by another blocker AP-5, implying that this effect of MK-801 is unrelated to its glutamate-blocking action. By contrast, MK-801, AP-5, and NMDA had no consistent effect on the volume of pits. In mice with GLAST glutamate transporters knocked out, no differences were detected in mandible and long bone size, morphology, trabeculation, regions of muscle attachment, resorption lacunae, or areas of formation versus resorption of bone, compared with wild-type siblings. These data suggest that glutamate does not play a major role in controlling bone growth.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0884-0431
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
742-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11316002-2-Amino-5-phosphonovalerate, pubmed-meshheading:11316002-ATP-Binding Cassette Transporters, pubmed-meshheading:11316002-Alveolar Bone Loss, pubmed-meshheading:11316002-Amino Acid Transport System X-AG, pubmed-meshheading:11316002-Animals, pubmed-meshheading:11316002-Animals, Newborn, pubmed-meshheading:11316002-Biological Transport, pubmed-meshheading:11316002-Bone Diseases, Metabolic, pubmed-meshheading:11316002-Bone Remodeling, pubmed-meshheading:11316002-Bone Resorption, pubmed-meshheading:11316002-Cells, Cultured, pubmed-meshheading:11316002-Dizocilpine Maleate, pubmed-meshheading:11316002-Excitatory Amino Acid Agonists, pubmed-meshheading:11316002-Excitatory Amino Acid Antagonists, pubmed-meshheading:11316002-Femur, pubmed-meshheading:11316002-Glutamic Acid, pubmed-meshheading:11316002-Glycine, pubmed-meshheading:11316002-Humerus, pubmed-meshheading:11316002-Mandible, pubmed-meshheading:11316002-Mice, pubmed-meshheading:11316002-Mice, Knockout, pubmed-meshheading:11316002-Models, Animal, pubmed-meshheading:11316002-N-Methylaspartate, pubmed-meshheading:11316002-Osteoblasts, pubmed-meshheading:11316002-Osteoclasts, pubmed-meshheading:11316002-Osteogenesis, pubmed-meshheading:11316002-Rats, pubmed-meshheading:11316002-Rats, Sprague-Dawley, pubmed-meshheading:11316002-Receptors, N-Methyl-D-Aspartate
pubmed:year
2001
pubmed:articleTitle
Glutamate does not play a major role in controlling bone growth.
pubmed:affiliation
Department of Anatomy, University College London, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't